107 related articles for article (PubMed ID: 2125023)
1. Failure to maintain high-dose treatment regimens during long-term use of zidovudine in patients with symptomatic human immunodeficiency virus type 1 infection.
van Leeuwen R; van den Hurk PJ; Jöbsis GJ; van der Wouw PA; Reiss P; Eeftinck Schattenkerk JK; Danner SA; Lange JM
Genitourin Med; 1990 Dec; 66(6):418-22. PubMed ID: 2125023
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.
McKinney RE; Pizzo PA; Scott GB; Parks WP; Maha MA; Lehrman SN; Riggs M; Eddy J; Lane BA; Eppes SC
J Pediatr; 1990 Apr; 116(4):640-7. PubMed ID: 2181102
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of zidovudine treatment in homosexual men with AIDS-related complex: factors influencing development of AIDS, survival and drug intolerance. Australian Zidovudine Study Group.
Swanson CE; Tindall B; Cooper DA
AIDS; 1994 May; 8(5):625-34. PubMed ID: 8060543
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of low-dose zidovudine in human immunodeficiency virus infection.
Collier AC; Bozzette S; Coombs RW; Causey DM; Schoenfeld DA; Spector SA; Pettinelli CB; Davies G; Richman DD; Leedom JM
N Engl J Med; 1990 Oct; 323(15):1015-21. PubMed ID: 1977080
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of treatment with AZT of patients with AIDS and symptomatic HIV infection.
Cox PH; Martin MA; Styer CM; Beall GN
Nurse Pract; 1990 May; 15(5):36, 39-44. PubMed ID: 2342666
[TBL] [Abstract][Full Text] [Related]
6. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy.
Pluda JM; Yarchoan R; Jaffe ES; Feuerstein IM; Solomon D; Steinberg SM; Wyvill KM; Raubitschek A; Katz D; Broder S
Ann Intern Med; 1990 Aug; 113(4):276-82. PubMed ID: 1973886
[TBL] [Abstract][Full Text] [Related]
7. Zidovudine therapy in an inner city population.
Samuels JE; Hendrix J; Hilton M; Marantz PR; Sloan V; Small CB
J Acquir Immune Defic Syndr (1988); 1990; 3(9):877-83. PubMed ID: 2384864
[TBL] [Abstract][Full Text] [Related]
8. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex.
Pinching AJ; Helbert M; Peddle B; Robinson D; Janes K; Gor D; Jeffries DJ; Stoneham C; Mitchell D; Kocsis AE
J Infect; 1989 Jan; 18 Suppl 1():33-40. PubMed ID: 2521663
[TBL] [Abstract][Full Text] [Related]
10. Early HIV infection: to treat or not to treat?
Swart AM; Weller I; Darbyshire JH
BMJ; 1990 Oct; 301(6756):825-6. PubMed ID: 2282416
[No Abstract] [Full Text] [Related]
11. Serum thymidine kinase--a marker of bone marrow toxicity during treatment with zidovudine.
Pedersen C; Ingeberg S; Teglbjaerg LS
AIDS; 1989 Nov; 3(11):743-6. PubMed ID: 2515880
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
Fischl MA; Parker CB; Pettinelli C; Wulfsohn M; Hirsch MS; Collier AC; Antoniskis D; Ho M; Richman DD; Fuchs E
N Engl J Med; 1990 Oct; 323(15):1009-14. PubMed ID: 1977079
[TBL] [Abstract][Full Text] [Related]
13. [Long-term success with zidovudine in HIV infection].
Leber Magen Darm; 1989 May; 19(3):158. PubMed ID: 2500573
[No Abstract] [Full Text] [Related]
14. Zidovudine--the first year of experience.
Williams I; Gabriel G; Cohen H; Williams P; Tedder RS; Machin S; Weller IV
J Infect; 1989 Jan; 18 Suppl 1():23-31. PubMed ID: 2915140
[No Abstract] [Full Text] [Related]
15. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: long-term experience.
Smiley L
J Infect; 1989 Jan; 18 Suppl 1():77. PubMed ID: 2644363
[No Abstract] [Full Text] [Related]
16. Current and future trials with zidovudine.
Yeo JM
J Infect; 1989 Jan; 18 Suppl 1():93-6. PubMed ID: 2644366
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of HIV infection with zidovudine. The good use of AZT].
Régnier B
Rev Prat; 1991 Sep; 41(19):1801-4. PubMed ID: 1925359
[No Abstract] [Full Text] [Related]
18. Factors influencing outcome of treatment with zidovudine of patients with AIDS in Australia. The Australian Zidovudine Study Group.
Swanson CE; Cooper DA
AIDS; 1990 Aug; 4(8):749-57. PubMed ID: 1979744
[TBL] [Abstract][Full Text] [Related]
19. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.
McKinney RE; Maha MA; Connor EM; Feinberg J; Scott GB; Wulfsohn M; McIntosh K; Borkowsky W; Modlin JF; Weintrub P
N Engl J Med; 1991 Apr; 324(15):1018-25. PubMed ID: 1672443
[TBL] [Abstract][Full Text] [Related]
20. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group.
Fischl MA; Richman DD; Causey DM; Grieco MH; Bryson Y; Mildvan D; Laskin OL; Groopman JE; Volberding PA; Schooley RT
JAMA; 1989 Nov; 262(17):2405-10. PubMed ID: 2677429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
